首页> 外国专利> for the application of pharmaceutical drugs such as systems with saturation solubility and high dissolution rate Manosuspension.

for the application of pharmaceutical drugs such as systems with saturation solubility and high dissolution rate Manosuspension.

机译:应用于诸如具有饱和溶解度和高溶出度Manosuspension的体系之类的药物。

摘要

SYSTEMS OBTAINED WITH ELEVATED SATURACION solubility (CS) Tucking COMPOUNDS IN PHARMACEUTICALS nanosuspensions. PHARMACEUTICAL COMPOUNDS IN WHOSE Bioavailability is very low because of its low saturation solubility, it can be increased by obtaining a nanosuspension. ADDITIONAL INCREASE THIS INCREASES THE CS dissolution rate simply by increasing the size of the surface. Nano-suspensions are achieved with high stability using very low of Surfactants and Stabilizers concentrations. Nanosuspensions MAY BE OBTAINED WITHOUT SURFACTANTS. MAY THE PREPARATION OF SCALE INDUSTRIAL nanosuspensions WITH A SMALL PARTICLE CONTENT THROUGH CAVITATION Millimeter and benefits associated with it. It was felt that a preparation Cavitation was not possible, since it was supposed to be a blockage of SLIT APPROX. 25 {MI} M BROADBAND BY THE MEDICINAL PARTICLE POWDER. Alternatively you CAN MAKE THE COURT ACTION BY PRODUCTION AND REBOUND IN FLUX dispersing machines using the above PRINCIPLES OF OPTIMA stabilization or preparation without surfactants.
机译:具有提高的饱和度溶解度(CS)的系统可将化合物塞入药物纳米悬浮液中。生物制药的生物利用度很低,因为它的饱和溶解度低,可以通过获得纳米悬浮液来提高其利用率。只需增加表面尺寸,即可增加CS的溶解速度。使用非常低的表面活性剂和稳定剂浓度,可以实现高稳定性的纳米悬浮液。不用表面活性剂即可获得纳米悬浮液。可能通过空化制备具有小颗粒含量的大规模工业纳米悬浮液,以及与之相关的收益。人们认为不可能进行气穴准备,因为它被认为是SLIT APPROX的障碍物。 25 {MI} M宽带由药用颗粒粉末制成。另外,您也可以使用上述OPTIMA稳定原理或在不使用表面活性剂的情况下,通过助焊剂分散机中的生产和回弹来进行法院诉讼。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号